MetaStat Inc MTST
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.00–0.05
- 52-Week Range
- $0.00–0.05
- Bid/Ask
- $0.00 / $0.08
- Shares Outstanding
- 5.88M
- Market Cap
- $4,114.17
- Volume/Avg
- 4,200 / 2,422
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 6
- Website
- https://www.metastat.com
Valuation
|
Metric
|
MTST
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MTST
Financial Strength
|
Metric
|
MTST
|
|---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.16 |
Interest Coverage | −25.67 |
Quick Ratio
MTST
Profitability
|
Metric
|
MTST
|
|---|---|
Return on Assets (Normalized) | −245.94% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MTST
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|gLmRfS^ | LOCK|wPhWB | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|N>QbhlG | LOCK|F%VJ | $83B | |||
| Moderna Inc
MRNA
| LOCK|yl&v?T | LOCK|px@ | $80B | |||
| argenx SE ADR
ARGX
| LOCK|k>wLbGb | LOCK|W<q | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&G#Mk! | LOCK|KB | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&$S%@M! | LOCK|Ft@J | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|?w&h%Jt | LOCK|HNqW# | $28B | |||
| Incyte Corp
INCY
| LOCK|HN@ry! | LOCK|<x | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|mRK%Y# | LOCK|t%> | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|VSg%vn$ | LOCK|qZ | $14B |
United States